BioCentury
ARTICLE | Company News

Calithera, Incyte deal

March 30, 2017 12:48 AM UTC

Calithera will receive a $12 million milestone payment from Incyte under a January deal granting Incyte exclusive, worldwide rights to CB-1158 for hematology and cancer indications. Calithera said the...